Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Antares Pharma (ATRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 392,075
  • Shares Outstanding, K 156,830
  • Annual Sales, $ 54,520 K
  • Annual Income, $ -16,740 K
  • 36-Month Beta 0.19
  • Price/Sales 7.19
  • Price/Cash Flow N/A
  • Price/Book 13.88

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.16 +12.50%
on 05/08/18
2.63 -7.60%
on 05/17/18
+0.15 (+6.58%)
since 04/25/18
3-Month
1.99 +22.11%
on 04/03/18
2.95 -17.63%
on 03/09/18
+0.08 (+3.40%)
since 02/23/18
52-Week
1.58 +53.80%
on 11/08/17
4.09 -40.59%
on 10/09/17
-0.12 (-4.71%)
since 05/25/17

Most Recent Stories

More News
Antares Pharma Reports First Quarter 2018 Operating and Financial Results

Antares Pharma, Inc. (NASDAQ:ATRS) (the Company) today reported operating and financial results for the first quarter ended March 31, 2018. The Company reported revenue of $12.7 million and a net loss...

ATRS : 2.43 (-2.80%)
Antares Pharma to Present at the Deutsche Bank Securities, Inc. 43rd Annual Health Care Conference

Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert Apple, President and Chief Executive Officer, will present at the Deutsche Bank Securities, Inc. 43rd Annual Health Care Conference on Wednesday,...

ATRS : 2.43 (-2.80%)
DB : 12.05 (-1.63%)
Antares Pharma to Report First Quarter 2018 Financial and Operating Results

Antares Pharma, Inc. (NASDAQ:ATRS) today announced it will release its first quarter 2018 financial results and recent operating progress before the market opens on Tuesday, May 8, 2018. Management will...

ATRS : 2.43 (-2.80%)
Pre-Market Technical Scan on Medical Supplies Equities -- Akers Biosciences, Antares Pharma, Baxter, and Becton, Dickinson and Co.

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on AKER, ATRS, BAX, and BDX which can be accessed for free by signing up to www.wallstequities.com/registration....

BDX : 223.73 (-0.83%)
AKER : 0.59 (+1.72%)
BAX : 72.53 (+0.17%)
ATRS : 2.43 (-2.80%)
Antares Pharma Provides XYOSTED(TM) Regulatory Update

Antares Pharma, Inc. (NASDAQ:ATRS) (the Company) today announced that the U.S. Food and Drug Administration (FDA or the Agency) acknowledged receipt of the Company's March 29, 2018 resubmission to the...

ATRS : 2.43 (-2.80%)
Antares Pharma Provides XYOSTED(TM) Regulatory Update

Antares Pharma, Inc. (NASDAQ:ATRS) (the Company) today announced that the official minutes from the Type A meeting with the U.S. Food and Drug Administration (FDA or the Agency) held on February 21, 2018...

ATRS : 2.43 (-2.80%)
Free Research Reports on These Medical Supplies Stocks -- Hill-Rom, NeuroMetrix, Akers Biosciences, and Antares Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on HRC, NURO, AKER, and ATRS which can be accessed for free by signing up to www.wallstequities.com/registration....

NURO : 1.37 (unch)
HRC : 90.81 (+0.01%)
AKER : 0.59 (+1.72%)
ATRS : 2.43 (-2.80%)
Antares Pharma to Present at the Cowen and Company 38th Annual Healthcare Conference

Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company 38 Annual Healthcare Conference on Wednesday March...

ATRS : 2.43 (-2.80%)
Antares Pharma to Report Fourth Quarter and Full Year 2017 Financial and Operating Results

Antares Pharma, Inc. (NASDAQ:ATRS) today announced it will release its fourth quarter and full year 2017 financial results and recent operating progress before the market opens on Tuesday, March 13, 2018....

ATRS : 2.43 (-2.80%)
Antares Pharma Announces Receipt of Second Installment from Sale of Zomajet(TM) Needle-Free Delivery System

Antares Pharma, Inc. (NASDAQ:ATRS) ("Antares") today announced that it has received $2.75 million from Ferring Pharmaceuticals ("Ferring") in connection with the previously disclosed sale of Antares' worldwide...

ATRS : 2.43 (-2.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade ATRS with:

Business Summary

Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes...

See More

Key Turning Points

2nd Resistance Point 2.53
1st Resistance Point 2.48
Last Price 2.43
1st Support Level 2.40
2nd Support Level 2.37

See More

52-Week High 4.09
Fibonacci 61.8% 3.13
Fibonacci 50% 2.84
Fibonacci 38.2% 2.54
Last Price 2.43
52-Week Low 1.58

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar